1. Patient Information Sheet Viagra®, US. Department of Health and Human Services, Food and Drug Administration, Rockville MD, USA, June 2005.
2. L. Blok-Tip, H. Vogelpoel, M.J. Vredenbregt, D.M. Barends, D. de Kaste, RIVM Report 267041001/2005, Bilthoven, The Netherlands.
3. National Specified List of Susceptible Products, National Association of Boards of Pharmacy, Mount Prospect II, USA, December 28th 2004.
4. Counterfeit Drugs, guidelines for the development of measures to combat counterfeit drugs, Department of Essential Drugs and Other Medicines, World Health Organization, Geneva, Switzerland, 1999.
5. Validation of a capillary gas chromatographic method for the determination of Sildenafil Citrate in its pharmaceutical formulations (Viagra). Experimental design for evaluating the ruggedness of the method